Insulin Nation

DECEMBER 18, 2013

A state-of-the-art wound therapy that prevents amputations is under threat from proposed cuts in Medicare reimbursement rates, according to regenerative medicine experts. In a recent Fierce Biotech article, CEO MacKay warned his staff of “heartbreaking” staff cuts to make the new pricing structure work.

Medicare 52

Medicare BioTech Pharmaceuticals 52

Health Populi

OCTOBER 28, 2019

published by the National Bureau of Economic Research found a close link between electoral politics and Medicare: that is, between legislative processes in the U.S. Between 2007 and 2014, hospital prices grew 42%. A recent study on politics and health care spending in the U.S. Congress and healthcare spending.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Total patient OOP costs in 2018 reached $61 billion, up $2 bn from 2017, and $5 bn from 2014. A cost of $125 or more yields abandonment of at least 50%.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149